Evidence map›Paper›PMID 37220419›Full record

ArticleACS chemical biology2023

Identification of Macrocyclic Peptide Families from Combinatorial Libraries Containing Noncanonical Amino Acids Using Cheminformatics and Bioinformatics Inspired Clustering.

Man-Ling Lee, Sherif Farag, Joselyn S Del Cid, Charlene Bashore, Kenneth K Hallenbeck, Alberto Gobbi, Christian N Cunningham

Abstract read
In one paragraph

Article in ACS chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. An mRNA Display Approach for Covalent Targeting of aJournal of the American Chemical Society · 2025
    Article
  3. Review
  4. An mRNA Display Approach for Covalent Targeting of abioRxiv : the preprint server for biology · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Man-Ling LeeDiscovery Chemistry, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Sherif FaragDiscovery Chemistry, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Joselyn S Del CidPeptide Therapeutics, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.ORCID 0000-0002-8958-4502
Charlene BashoreBiological Chemistry, Genentech Inc. 1 DNA Way, South San Francisco, California 94080, United States.
Kenneth K HallenbeckPeptide Therapeutics, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Alberto GobbiDiscovery Chemistry, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.ORCID 0000-0003-0434-9237
Christian N CunninghamPeptide Therapeutics, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.ORCID 0000-0003-3993-660X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past decade, macrocyclic peptides gained increasing interest as a new therapeutic modality to tackle intracellular and extracellular therapeutic targets that had been previously classified as "undruggable". Several technological advances have made discovering macrocyclic peptides against these targets possible: 1) the inclusion of noncanonical amino acids (NCAAs) into mRNA display, 2) increased availability of next generation sequencing (NGS), and 3) improvements in rapid peptide synthesis platforms. This type of directed-evolution based screening can produce large numbers of potential hit sequences given that DNA sequencing is the functional output of this platform. The current standard for selecting hit peptides from these selections for downstream follow-up relies on the frequency counting and sorting of unique peptide sequences which can result in the generation of false negatives due to technical reasons including low translation efficiency or other experimental factors. To overcome our inability to detect weakly enriched peptide sequences among our large data sets, we wanted to develop a clustering method that would enable the identification of peptide families. Unfortunately, utilizing traditional clustering algorithms, such as ClustalW, is not possible for this technology due to the incorporation of NCAAs in these libraries. Therefore, we developed a new atomistic clustering method with a Pairwise Aligned Peptide (PAP) chemical similarity metric to perform sequence alignments and identify macrocyclic peptide families. With this method, low enriched peptides, including isolated sequences (singletons), can now be clustered into families providing a comprehensive analysis of NGS data resulting from macrocycle discovery selections. Additionally, upon identification of a hit peptide with the desired activity, this clustering algorithm can be used to identify derivatives from the initial data set for structure-activity relationship (SAR) analysis without requiring additional selection experiments.

Indexed as

Amino AcidsCheminformaticsCluster AnalysisComputational BiologyHumansPeptide LibraryPeptidesAmino AcidsPeptide LibraryPeptides

Identifiers

PMID37220419
PMCPMC10278063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.